The Europe Vacuum Blood Collection Tube Market would witness market growth of 1.3% CAGR during the forecast period (2022-2028).
When collecting the blood sample, the patient must be positively recognized. Making sure the right patient's blood sample is obtained requires accurate patient identification. The possibility of a mistake in the specimen collection and handling process is probably higher than the possibility of error in the actual treatment. It is important to pay close attention to how specimens are collected and handled.
The method for collecting specimens that are most often utilized is the evacuated tube system. Since this approach enables blood to move straight from the vein to the evacuated tube, it is superior to the needle and syringe method. The evacuated tube method reduces the risk of needlesticks, aids in the elimination of certain labeling mistakes, and lessens the chance of using the wrong specimens.
In France, the market for medical devices generated an estimated €31.2 billion in revenue in 2019. An €8.9 billion turnover for medical device exports from France is estimated, or 26% of the market. For the next several years, the industry is anticipated to rise by roughly 2% annually. The potential for the adoption of novel technology and devices is shown by the growing medical device market. Additionally, it is anticipated that more individuals will get diabetes in the UK over the next 20 years, rising from 3.9 million in 2017 to 4.9 million in 2035. Diabetes has an increased risk due to obesity, and this risk will grow if obesity becomes more common. This increases the market's requirement for healthcare infrastructure that is effective enough. These reasons are expected to cause the vacuum blood collection tube market in European countries to expand steadily.
The Germany market dominated the Europe Vacuum Blood Collection Tube Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $208 million by 2028.The UK market is anticipated to grow at a CAGR of 0.5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 2.1% during (2022 - 2028).
Based on Material, the market is segmented into PET/Plastic and Glass. Based on Application, the market is segmented into Blood Routine Examination, Serology & Immunology, Blood Sugar Assay, Coagulation Tests & Genetic Studies and Others. Based on End-use, the market is segmented into Pathology Laboratories, Hospitals & Clinics and Blood Banks. Based on Type, the market is segmented into Serum Separating Tubes, Plasma Separation Tubes, EDTA Tubes, Rapid Serum Tubes, Coagulation Tubes and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Vacuum Blood Collection Tube Market will Hit $3.2 Billion by 2028, at a CAGR of 1.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Cardinal Health, Inc., Sekisui Chemical Co., Ltd., Greiner AG, Hindustan Syringes & Medical Devices Ltd., OÜ InterVacTechnology, Advin Health Care, AdvaCare Pharma, MB Plastic Industries, and CML Biotech (P) Ltd.
By Material
By Application
By End-use
By Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
